Alteration of thyroid functions in patients with renal cell carcinoma treated with tyrosine kinase inhibitors; Turkish population study.

Cemil BİLİR; İbrahim YILDIZ; Ahmet BİLİCİ; Mahmut UÇAR; Veli BERK; Yaşar YILDIZ; Ozan YAZICI; Gökşen İnanç İMAMOĞLU; Nuri KARADURMUŞ; Kezban Nur PİLANCI; Erkan ARPACI; Özgür TANRIVERDİ; Ebru KARCI; Süleyman TEMİZ; Erdinç NAYIR; Esin OKTAY; Pınar DAL; İbrahim PETEKKAYA; Onur YAĞMURKAYA; Ceyhun VARIM

Article Details

Alteration of thyroid functions in patients with renal cell carcinoma treated with tyrosine kinase inhibitors; Turkish population study.

Authors:

Cemil BİLİR | İbrahim YILDIZ | Ahmet BİLİCİ | Mahmut UÇAR | Veli BERK | Yaşar YILDIZ | Ozan YAZICI | Gökşen İnanç İMAMOĞLU | Nuri KARADURMUŞ | Kezban Nur PİLANCI | Erkan ARPACI | Özgür TANRIVERDİ | Ebru KARCI | Süleyman TEMİZ | Erdinç NAYIR | Esin OKTAY | Pınar DAL | İbrahim PETEKKAYA | Onur YAĞMURKAYA | Ceyhun VARIM

Publisher:

Ramazan AKDEMİR

Journal:

Journal of Human Rhythm 2016 Vol.2 Issue 4, pp.144-148

Document Type:

Article

Publication Date:

12/2016

Document Language:

Turkish

Document ID (Org No.):

2000739887

Frequency:

Quarterly

eISSN:

2149-455X

Abstract:

 


Background Studies investigated different side effects of TKIs such as hypertension, dermatologic side effects and hormonal changes. Thyroid hormones

change is take an interest for last decade and phase 2 and 3 trial result had been analyzed retrospectively for this reason.

Method A totally 246 metastatic renal cell carcinoma patients who were treated with TKI included in the study and they recruited from over 10 different oncology clinics.

Results In the study 246 mRCC patients included and mean age was 60 (±8), and 183 (74%) of them were male, 63 (24%) of them were female.Following TKI therapy 15 patients (6%) became as a hyperthyroidic, 83 patients (34%) became hypothyroidic and remaining 148 patients

had in normal range for TSH levels. When we subgroup the patients according to the TSH change, in 38 patients (15.4%) had THS decreasing at least 50% from baseline and 128 patients (52%) has elevated THS levels as described previous range. In survival analyses, became hyperthyroidic patients had significantly longer OS than became hypothyrodic patients (25.4 vs 14 months, P=0.036) but no significantly differ than remained normothyroidic patients (25.4 vs 18 months, P=0.16).

Conclusion patients who had decreasing TSH levels under the treatment of TKI should have significantly higher overall survival but, hypothyroid patientsdon’t.

.

Article Details

Alteration of thyroid functions in patients with renal cell carcinoma treated with tyrosine kinase inhibitors; Turkish population study.

Publisher: Ramazan AKDEMİR

Journal: Journal of Human Rhythm 2016 Vol.2 Issue 4, pp.144-148

Document Type: Article

Publication Date: 12/2016

Document Language: Turkish

Document ID (Org No.): 2000739887

Frequency: Quarterly

eISSN: 2149-455X

Issues

Publisher:

Ramazan AKDEMİR

Journal:

Journal of Human Rhythm 2016 Vol.2 Issue 4, pp.144-148

Document Type:

Article

Publication Date:

12/2016

Document Language:

Turkish

Document ID (Org No.):

2000739887

Frequency:

Quarterly

eISSN:

2149-455X